Hereditary factor in early prostate cancer:
This article was originally published in Clinica
Executive Summary
Prostate cancer has a strong familial factor affecting younger patients. Familial prostate cancer is transmitted in an autosomal dominant manner, says a review in the Canadian Medical Association Journal (Vol. 153, pp 895-900). The familial condition accounts for 43% of cases in men under 55 years, but only 9% of prostate cancer cases overall.
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.